Knight Therapeutics, Inc. (GUD.TO)
10.83
+0.10
(+0.93%)
CAD |
TSX |
Oct 09, 16:00
Knight Therapeutics Profit Margin (Quarterly) : -2.33% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.33% |
| March 31, 2026 | 8.87% |
| December 31, 2025 | 6.65% |
| September 30, 2025 | -3.12% |
| June 30, 2025 | -11.76% |
| March 31, 2025 | 2.48% |
| December 31, 2024 | 11.08% |
| September 30, 2024 | 0.09% |
| June 30, 2024 | -2.03% |
| March 31, 2024 | -5.25% |
| December 31, 2023 | -32.79% |
| September 30, 2023 | 11.76% |
| June 30, 2023 | 2.05% |
| March 31, 2023 | -4.77% |
| December 31, 2022 | -18.60% |
| September 30, 2022 | 2.20% |
| June 30, 2022 | 3.32% |
| March 31, 2022 | -29.48% |
| December 31, 2021 | -14.24% |
| September 30, 2021 | -11.71% |
| June 30, 2021 | 44.08% |
| March 31, 2021 | 7.72% |
| December 31, 2020 | 14.92% |
| September 30, 2020 | 38.67% |
| June 30, 2020 | 29.13% |
| Date | Value |
|---|---|
| March 31, 2020 | -20.67% |
| December 31, 2019 | -8.46% |
| September 30, 2019 | -73.42% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 5.68% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 18.51% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 44.66% |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -5.41K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -6.95% |
| Bausch Health Cos., Inc. | 9.12% |
| Cipher Pharmaceuticals, Inc. | 33.26% |
| BioSyent, Inc. | 14.34% |
| Revive Therapeutics Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.91% |
| Return on Assets | 1.41% |
| Return on Invested Capital | 1.74% |
| Gross Profit Margin (Quarterly) | 38.94% |
| Operating Margin (Quarterly) | 6.21% |
| Return on Net Operating Assets | 1.98% |